These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28286532)

  • 1. Efficacy of Juzentaihoto for Tumor Immunotherapy in B16 Melanoma Metastasis Model.
    Ishikawa S; Ishikawa T; Tezuka C; Asano K; Sunagawa M; Hisamitsu T
    Evid Based Complement Alternat Med; 2017; 2017():6054706. PubMed ID: 28286532
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressive effect of juzen-taiho-to on lung metastasis of b16 melanoma cells in vivo.
    Matsuda T; Maekawa K; Asano K; Hisamitsu T
    Evid Based Complement Alternat Med; 2011; 2011():743153. PubMed ID: 19131394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effect of juzentaihoto on vascularization induced by b16 melanoma cells in vitro and in vivo.
    Ishikawa S; Ishikawa T; Asano K; Fujiwara H; Okada M; Sunagawa M; Hisamitsu T
    Evid Based Complement Alternat Med; 2012; 2012():945714. PubMed ID: 22110549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juzentaihoto Exerts Anti-Allergic Effects by Inhibiting Effector T-Cell Activation and Inducing and/or Activating Regulatory T Cells in a Murine Model of Contact Hypersensitivity.
    Tsuge A; Yonekura S; Watanabe S; Kurosaki Y; Hisaka S; Nose M
    Int Arch Allergy Immunol; 2022; 183(1):1-13. PubMed ID: 34818253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 and IL-18 induction and subsequent NKT activation effects of the Japanese botanical medicine Juzentaihoto.
    Fujiki K; Nakamura M; Matsuda T; Isogai M; Ikeda M; Yamamoto Y; Kitamura M; Sazaki N; Yakushiji F; Suzuki S; Tomiyama J; Uchida T; Taniguchi K
    Int J Mol Sci; 2008 Jun; 9(7):1142-1155. PubMed ID: 19325795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma.
    Kim TS; Xu WS; Sun T; Cohen EP
    Melanoma Res; 1995 Aug; 5(4):217-27. PubMed ID: 7496156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-metastatic activity induced by the in vivo activation of purified protein derivative (PPD)-recognizing Th1 type CD4+ T cells.
    Shinomiya Y; Harada M; Kurosawa S; Okamoto T; Terao H; Matsuzaki G; Shirakusa T; Nomoto K
    Immunobiology; 1995 Aug; 193(5):439-55. PubMed ID: 8522359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody.
    Eisenthal A; Cameron RB; Rosenberg SA
    J Immunol; 1990 Jun; 144(11):4463-71. PubMed ID: 2111349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine.
    Pope BL; Sigindere J; Chourmouzis E; MacIntyre P; Goodman MG
    Cancer Immunol Immunother; 1994 Feb; 38(2):83-91. PubMed ID: 8306370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-18 and the costimulatory molecule B7-1 have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy.
    Cho D; Kim TG; Lee W; Hwang YI; Cho HI; Han H; Kwon O; Kim D; Park H; Houh D
    J Invest Dermatol; 2000 May; 114(5):928-34. PubMed ID: 10771473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice.
    Iwasawa T; Nojiri S; Tsuchiya A; Takeuchi S; Watanabe T; Ogawa M; Motegi S; Sato T; Kumagai M; Nakaya T; Ohbuchi K; Nahata M; Fujitsuka N; Takamura M; Terai S
    Regen Ther; 2021 Dec; 18():231-241. PubMed ID: 34409135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents.
    Saijo N; Ozaki A; Beppu Y; Takahashi K; Fujita J; Sasaki Y; Nomori H; Kimata M; Shimizu E; Hoshi A
    J Cancer Res Clin Oncol; 1984; 107(3):157-63. PubMed ID: 6736102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese Kampo Medicine Juzentaihoto Enhances Antitumor Immunity in CD1d
    Takaku S; Shimizu M; Takahashi H
    Integr Cancer Ther; 2020; 19():1534735419900798. PubMed ID: 31959018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice.
    Takeda K; Nakayama M; Sakaki M; Hayakawa Y; Imawari M; Ogasawara K; Okumura K; Smyth MJ
    J Leukoc Biol; 2011 Oct; 90(4):777-85. PubMed ID: 21712396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity.
    Gorelik E; Wiltrout RH; Brunda MJ; Bere WE; Herberman RB
    Clin Exp Metastasis; 1985; 3(2):111-23. PubMed ID: 4042460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of B16 melanoma metastasis by the immunomodulator AS101.
    Xu R; Kalechman Y; Albeck M; Kung H; Sredni B
    Int J Oncol; 1996 Aug; 9(2):319-25. PubMed ID: 21541518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tumor growth through inhibition of tumor vessel formation.
    Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
    J Invest Dermatol; 2002 Sep; 119(3):541-8. PubMed ID: 12230493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-metastatic effect by in vivo administration of concanavalin A through augmentation of T-derived activated killer activity: efficacy to B16 melanoma expressed MHC antigen.
    Taniguchi K; Kawano YI; Toshitani A; Karashima A; Nomoto K
    Cell Immunol; 1989 May; 120(2):460-9. PubMed ID: 2785862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-induced alterations in metastatic capacity, class-1 antigen expression and natural killer cell sensitivity of melanoma cells.
    McMillan TJ; Rao J; Everett CA; Hart IR
    Int J Cancer; 1987 Nov; 40(5):659-63. PubMed ID: 2445702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.